Scientists try radiation 'Boost' to reawaken failed cancer treatment
NCT ID NCT05401786
Summary
This study is for people with advanced non-small cell lung cancer whose disease progressed after standard immunotherapy. Researchers want to see if adding a different immunotherapy drug (ipilimumab) and targeted radiation to a few tumors can help patients respond again to the original treatment (cemiplimab). The study will enroll 54 participants and involves blood tests and tumor biopsies to understand how the combination works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antoni van Leeuwenhoek - Netherlands Cancer Institute
Amsterdam, North Holland, 1066 CX, Netherlands
Conditions
Explore the condition pages connected to this study.